What's Happening?
The Royal Pharmaceutical Society (RPS) has published a comprehensive overview of its research achievements in 2025, marking a 25% increase in published articles compared to the previous year. The RPS's four research journals, in partnership with Oxford
University Press, covered a wide range of topics including new drug developments for cancer and kidney disease, antimicrobial resistance, and sustainable medicine practices. The International Journal of Pharmacy Practice focused on sustainable medicine use, while the Journal of Pharmaceutical Health Services Research emphasized transparency and accountability in pharmaceutical systems. The Journal of Pharmacy and Pharmacology celebrated its 25th anniversary with a special collection, and RPS Pharmacy & Pharmacology Reports welcomed new editorial leadership. These journals play a crucial role in advancing pharmacy practice by disseminating high-quality research.
Why It's Important?
The RPS's research publications are significant as they contribute to the advancement of pharmacy practice and patient care. By addressing critical issues such as sustainable medicine use and transparency in pharmaceutical systems, these journals help shape policies and practices that can lead to improved healthcare outcomes. The increase in published articles reflects a growing interest and investment in pharmaceutical research, which is essential for developing innovative solutions to healthcare challenges. The focus on topics like antimicrobial resistance and drug development highlights the ongoing efforts to combat global health threats and improve treatment options for patients.
